In this issue, Dr. Stoyan Borisov presents his clinical assessment study on the effect of Coriolus versicolor supplementation on patients with Low-risk and High-risk HPV subtypes. Dr. Chris Newton (Ph.D) proposes a study on the potential role of mushroom nutrition as modulators of toll receptor-mediated immune response.
The enzyme researcher, Dr. Amin Karmali (Ph.D) presents a detoxification analysis (in vitro) on mushroom nutrition, outlining the superoxide dismutase activity, cytochrome P450, cytochrome P450 reductase and secondary metabolites activity of Grifola frondosa (Maitake), Ganoderma lucidum (Reishi), Coriolus versicolor and Cordyceps sinensis.
Finally, the latest poster presentation on the efficacy of Coriolus versicolor in the treatment of HPV lesions (LSIL), presented by Dr. J.Silva Couto at the 14th World Congress of Cervical Pathology and Colpscopy- (IFCPC)-July 4th to 7th, 2011 in Rio de Janeiro, Brasil.
The Clinical Journal of Mycology (formerly Mycology News) is dedicated to the dissemination of information on the clinical use of mushroom nutrition to health care practitioners. In this issue we address the role of Coriolus versicolor in the treatment of CIN-1 (LSIL HPV) and Herpes Simplex.
Dr J Silva Couto outlines the difference between LSIL and HSIL HPV and provides a protocol for use by medical professionals. In addition, Prof Amin Karmali explains the enzymatic qualities of Coriolus versicolor and how such attributes assist the immune system. Finally, Dr. Andrew French outlines his clinical experience using Coriolus versicolor in patients with herpes simplex with a recommended protocol for consultants.
In this fourth edition, a review of the causal link between viruses and the onset of specific cancers is examined. A detailed study, conducted by Breakspear Medical Group, on the impact of supplementation with Coriolus-MRL in Chronic Fatigue Syndrome patients and ensuing improvement in both Natural Killer Cell activity and symptoms is presented. Furthermore, a set of three case studies on the use of Coriolus-MRL as an adjunct in radiotherapy conducted in the Institute of Oncology in Lisbon, Portugal is presented.